JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
JAMA Network

JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

2024-10-24
Download

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

  • Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
Comments (3)

More Episodes

All Episodes>>

You may also like

JAMA Clinical Reviews
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Internal Medicine Author Interviews
JAMA Psychiatry Author Interviews
JAMA Neurology Author Interviews
JAMA Dermatology Author Interviews
JAMA Author Interviews
JAMA Pediatrics Editors’ Summary

Get this podcast on your phone, Free

Download Podbean app on App Store Download Podbean app on Google Play

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free